Betahistine dimethanesulfonate is a histamine H1 receptor agonist and H3 receptor antagonist classified as a vasodilator, primarily indicated for the treatment of vertigo, Meniere's disease, and associated… Read more
Betahistine dimethanesulfonate is a histamine H1 receptor agonist and H3 receptor antagonist classified as a vasodilator, primarily indicated for the treatment of vertigo, Meniere's disease, and associated balance disorders. By modulating histamine receptors in the inner ear and brain, it helps reduce the symptoms of dizziness and motion sickness. This category contains a comprehensive range of reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for precise analytical testing and method validation throughout the drug development lifecycle. Specifically, stable isotope labelled internal standards are crucial for accurate quantification in complex matrices, while impurity standards support detailed impurity profiling and quality control to ensure regulatory compliance and therapeutic consistency of the active pharmaceutical ingredient.